End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.185 NZD | +1.16% | +0.23% | -1.13% |
13/03 | Vital Healthcare Property Trust Declares DRP Strike Price for Q2 Dividend | MT |
15/02 | Vital Healthcare Property Trust Widens Net Loss in Fiscal H1 | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company is one of the best yield companies with high dividend expectations.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- One of the major weak points of the company is its financial situation.
- Based on current prices, the company has particularly high valuation levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Most analysts recommend that the stock should be sold or reduced.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.13% | 844M | D+ | ||
+4.91% | 55.76B | A- | ||
-9.33% | 17.64B | A- | ||
-4.87% | 13.29B | A | ||
+0.99% | 7.58B | B | ||
-17.41% | 5.54B | B- | ||
+12.58% | 3.37B | C- | ||
-0.98% | 3.22B | C+ | ||
-2.36% | 3.05B | B+ | ||
-2.13% | 2.8B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- VHP Stock
- Ratings Vital Healthcare Property Trust